Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Plus Therapeutics Inc logo

Plus Therapeutics Inc

Sector: Manufacturing   

Industry: Surgical and Medical Instrument Manufacturing

2.00
 
USD
  
-0.13
  
(-6.10%)
Optionable: No  Market Cap: 12 M  90-day average vol: 74,799

Previous close: 2.13  Open: 2.03  Bid: 1.88  Ask: 2.15
52 week range    
0.97   
   3.21
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

PSTV Income Statement

Annual
Dec-12Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends1 M4 M6 M8 M
AcquiredInProcessRnDIncome3 M
Amortization of intangibles-192000.0-49000.0-185000.0-584000.0-1 M-1 M-32000.0-100000.0
Basic EPS total-1.11-0.77
Basic weighted shares outstanding4 M5 M5 M1 M2 M579503.092267.0295189.0805945.026 M
Cost of sales-4 M-3 M-3 M2 M-1 M-1 M
Depreciation-741000.0-2 M-594000.0-700000.0-900000.0-300000.0-900000.0-400000.0-400000.0-500000.0
Depreciation unreconciled545000.01 M1 M
DepreciationAndAmortization-741000.0-2 M-594000.0545000.01 M-300000.0-900000.0-400000.0-400000.0-500000.0
DevelopmentExpense2 M
Diluted EPS total-8.25-5.85-7.2-19.2-12.3-26.1-5.49-1.86-16.65-0.77
Diluted normalized net income/share-16.65
Diluted weighted shares outstanding4 M4 M5 M1 M2 M522375.0295189.0805945.026 M
DilutedDiscontinuousOperations-82.35
Earnings from equity interest-165000.0-48000.0
EarningsFromEquityInterestNetOfTax-165000.0-48000.0
GainOnSaleOfBusiness5 M
GainOnSaleOfPPE-257000.042000.07 M-66000.0
GainOnSaleOfSecurity3 M6000.0
GainsLossOnDisposalOfDiscontinuedOperations-4 M-8 M
GeneralAndAdministrativeExpense16 M16 M16 M9 M8 M6 M5 M6 M7 M10 M
Gross operating profit5 M4 M2 M2 M5 M5 M2 M224000.0
Income before tax-32 M-25 M-37 M-22 M-23 M-9 M-3 M-8 M-13 M-20 M
Income restructuring and M&A-221000.0-2 M
Income taxes708000.0
Interest income4000.04 M6000.019000.033000.0-427000.0-1 M50000.019000.0147000.0
InterestExpenseNonOperating3 M3 M4 M3 M2 M2 M2 M1 M932000.0711000.0
InterestIncomeOperating2 M
MiscOtherSpecialCharges-314000.0-20000.0-239000.0233000.013000.02 M-3 M-2 M-6000.01000.0
Net income from total operations-32 M-26 M-37 M-22 M-23 M-13 M-11 M-8 M-13 M-20 M
NetIncomeCommonStockholders-32 M-26 M-39 M-22 M-27 M-19 M-19 M-8 M-13 M-20 M
NetIncomeContinuousOperations-32 M-26 M-37 M-22 M-23 M-13 M-11 M-8 M-13 M-20 M
NetIncomeDiscontinuousOperations-4 M-8 M
NetNonOperatingInterestIncomeExpense-3 M1 M-4 M-3 M-2 M-2 M-3 M-1 M-913000.0-564000.0
Operating income-28 M-31 M-33 M-20 M-21 M-9 M-4 M-10 M-12 M-20 M
Operating income before depreciation (EBITDA)-27 M-20 M-31 M-17 M-18 M-4 M18000.0-6 M-12 M-18 M
OperatingExpense-39 M-39 M-37 M-28 M-25 M-12 M-11 M10 M12 M-20 M
Other income net479000.0-5 M197000.0-233000.0-13000.0-2 M-3 M2 M60000.0-1000.0
OtherGandA16 M16 M16 M9 M8 M6 M5 M6 M7 M10 M
OtherOperatingExpenses131000.0-2 M-37 M-87000.0-95000.0-61000.0-225000.0-33000.0-69000.0-159000.0
OtherunderPreferredStockDividend1 M4 M6 M8 M
PreferredStockDividends1 M4 M6 M8 M
RentAndLandingFees16 M16 M16 M9 M8 M6 M5 M6 M-7 M10 M
Research & development expense14 M17 M15 M16 M13 M6 M5 M3 M6 M10 M
ResearchExpense14 M17 M15 M16 M12 M6 M5 M3 M6 M10 M
RestructringAndMnAIncome-221000.0-2 M
Revenue per share-1 M-942000.0-1,220 M545000.01 M-600000.0-500000.0-600000.0-532000.0-500000.0
SalariesAndWages-6 M-5 M-3 M-7 M-753000.0-3 M-7 M-303000.0-606000.0-606000.0
Selling Gen & administrative expense25 M25 M22 M12 M11 M6 M5 M6 M7 M10 M
SellingAndMarketingExpense9 M9 M6 M4 M4 M643000.0468000.0
SellingExpense9 M9 M6 M4 M4 M643000.0468000.0
Special income/charges221000.02 M
Total Income available for interest expense (EBIT)-29 M-22 M-33 M-19 M-21 M-7 M-1 M-7 M-12 M-20 M
Total net income-32 M-26 M-37 M-22 M-23 M-13 M-11 M-8 M-13 M-20 M
Total ordinary shares6 M6 M6 M6 M6 M6 M6 M6 M6 M6 M
Total revenues9 M7 M5 M5 M3 M3 M2 M224000.0
TotalExpenses-43 M-43 M-40 M-26 M-26 M-12 M-11 M10 M12 M-20 M
TotalRevenue9 M5 M5 M5 M3 M4 M2 M224000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University